Charles River Laboratories Hits New 52-Week High at $236.28

Charles River Laboratories International, Inc. has reached a significant milestone by hitting a new 52-week high of USD 236.28 on July 1, 2026. This achievement highlights the stock's upward momentum within the miscellaneous industry, where it operates as a small-cap company with a market capitalization of USD 7,858 million. Over the past year, Charles River Laboratories has demonstrated a performance increase of 6.8%, although it trails behind the S&P 500's performance of 20.74%. The company's price-to-earnings (P/E) ratio stands at 26.00, indicating its valuation relative to earnings. Additionally, the stock's price-to-book ratio is 2.48, reflecting its market value compared to its book value. With a debt-to-equity ratio of 0.62 and a return on equity of 9.58%, Charles River Laboratories maintains a balanced financial structure. Notably, the company does not offer a dividend yield, which is consistent with many growth-oriented firms in its sector. The stock's previous 52-week low was recorded at USD 144.26, marking a substantial increase in value over the past year.